Lesion localisation + sentinel node biopsy in one platform.

Wire-free, radiation-free breast cancer localisation

Easy and intuitive to use, the Sentimag® system provides precise localisation for breast cancer physicians.

Precise localisation

Sentimag® system for breast cancer localisation

The Sentimag® localisation system is the heart of our localisation technology platform. Using magnetic sensing it detects our magnetic markers, Magseed® and Magtrace®, enabling physicians to carry out tumour localisations and breast cancer staging with one platform.

By adding greater flexibility, precision and removing the need for both wires and nuclear medicine, our platform is revolutionising breast cancer care.

Our products

Overview

Sentimag® system features + benefits

1

Intuitive and ergonomic probe

Easy to use with a very short learning curve

2

Audio and visual prompts

Large two-colour digital display with adjustable volume for easy detection read-outs

3

Ultra-sensitive design

Allows you to work quickly with great precision

4

Multi-use platform

Can be used with Magseed® and Magtrace® markers for both tissue localisation and sentinel node biopsy respectively

5

Instant feedback

When localising you need instant feedback, and the Sentimag® system gives you this

6

360° sensing

A system that boasts no dead spots compared to other technologies

Trusted by experts

The Sentimag® system is trusted by the world’s best cancer surgeons. Listen to their personal experiences of using the Sentimag® probe to localise our Magseed® and Magtrace® markers in their daily care.

"As a pioneering group in the field of breast cancer treatment, the innovation that we do is not just for our own patients. What we want to do is to set an example for other institutions, other community hospitals. We want them to realise that we've adopted Magtrace and Magseed, and it's been a very easy and nice conversion from the old technique, to the new technique. We really want these other institutions to start utilizing this, because it really is better for patients."

Michael Alvarado, MD

Professor of Surgery, Director, Breast Surgery Fellowship, University of California, San Francisco

"As a pioneering group in the field of breast cancer treatment, the innovation that we do is not just for our own patients. What we want to do is to set an example for other institutions, other community hospitals. We want them to realise that we've adopted Magtrace and Magseed, and it's been a very easy and nice conversion from the old technique, to the new technique. We really want these other institutions to start utilizing this, because it really is better for patients."

Michael Alvarado, MD

Professor of Surgery, Director, Breast Surgery Fellowship, University of California, San Francisco